Oracle Head and Neck Cancer UK Limited — grant history

Registered charity 1142037 · filings on the Charity Commission register · its own accounts analysis · funder finder · deadlines

Latest income
£648k
Grants listed (FY2024)
0
Listed grants total
Accounts grants total
£3k

extracted from its FY2024 accounts

Application guidance — from the funder’s own website

Summarised from www.oraclehnc.org.uk · oraclehnc.org.uk/get-involved/fundraise · oraclehnc.org.uk/healthcare-professionals-researchers/research/research-and-funding-strategy on 15/08/2026. Always check the funder’s site before applying.

What this funder supports

Based on the register classifications and operating areas of the grant recipients we could match to the charity register (a subset of all grantees).

Causes funded
Where grantees operate
  • Cheshire East (1 grantee)
  • Cheshire West & Chester (1 grantee)
  • Norfolk (1 grantee)
  • Throughout England And Wales (1 grantee)

Grants made, per its accounts filings

Download this grant history as CSV (open data, provenance and licence noted in the file).

RecipientYearAmountPurpose
Newcastle University NHS FoundationFY2023£125kInequalities project (co-funded with North West Cancer Research)
Institute of Cancer ResearchFY2023£58kCHK/ AMRC/ Mason Le Page for Koteva
Institute of Cancer ResearchFY2023£53kAMRC/ Swire Pioneers of Discovery for Fleming and Melake
Institute of Cancer ResearchFY2023£34kBeaumont/ Terradace for Marsh
Institute of Cancer ResearchFY2023£32kAMRC for Patin
Institute of Cancer ResearchFY2023£31kAMRC for Lin
Institute of Cancer ResearchFY2023£26kAMRC for Cicero/Sala
Institute of Cancer ResearchFY2023£25kAMRC for Freckleton
Institute of Cancer ResearchFY2023£18kAMRC for Chan
University of Derby NHS TrustFY2023£17kCHK/ AMRC/ Mason Le Page for Koteva (Note: Note 13 lists this under CHK/AMRC/Mason Le Page, but text links CHK to ICR. However, Note 13 breakdown shows specific amounts. Let's look at Note 13 carefully. The note lists 'CHK/ AMRC/ Mason Le Page for Koteva' with income 38,076 and expenditure (37,500). Wait, the table in Note 13 is complex. Let's re-read Note 13 'Restricted Funds'. It lists specific funds. The 'Balance 31 May 2023' column shows the remaining balance. The 'Expenditure' column shows what was spent. The 'Income' column shows what was received. The question asks for grants PAID OUT. The expenditure column represents the grants paid/charged to the fund. Let's extract the expenditure amounts for the named research funds.
University of Derby NHS TrustFY2023£16kBeaumont/Terradace/AMRC for Patin (Note: Text says Beaumont/Terradace/AMRC for Patin. Note 13 lists 'Beaumont/ Terradace/ AMRC for Patin' with expenditure 22,725? No, let's look at the rows in Note 13 again. The rows are: 'CHK/ AMRC/ Mason Le Page for Koteva', 'AMRC/ Swire Pioneers of Discovery for Fleming and Melake', 'AMRC for Patin', 'Beaumont/Terradace for Marsh', 'AMRC for Lin', 'AMRC for Cicero/Sala', 'AMRC for Freckleton', 'AMRC for Chan', 'Inequalities project', 'University of Southampton for Lola internship', 'Mercers Livery', 'Pennycress Trust'. The columns are Balance 1 June, Transfers, Income, Expenditure, Balance 31 May. The 'Expenditure' column is the grants paid. Let's map them.
University of SouthamptonFY2023£14kUniversity of Southampton for Lola internship
Institute of Cancer ResearchFY2023£13kAMRC/ Swire Pioneers of Discovery for Fleming and Melake
Institute of Cancer ResearchFY2023£12kAMRC for Patin
University of Derby NHS TrustFY2023£1kPennycress Trust
University of Derby NHS TrustFY2023£1kMercers Livery
Institute of Cancer ResearchFY2023£1kAMRC for Cicero/Sala
Institute of Cancer ResearchFY2023£1kAMRC for Freckleton
Institute of Cancer ResearchFY2023£1kAMRC for Chan
Newcastle University NHS FoundationFY2023£1kInequalities project
University of Derby NHS TrustFY2023£1kBeaumont/Terradace for Marsh
University of Derby NHS TrustFY2023£1kCHK/ AMRC/ Mason Le Page for Koteva
Swire- Pioneers of Discovery (Fleming and Melake)FY2022£53kPhD fellows in establishing their careers in the field, while directing more innovative research towards head and neck cancer.
Chellaram (Hobart)FY2022£37kPhD project looking at how medical imaging can be used to predict how likely a head and neck cancer patient is to respond to immunotherapy treatment.
Beaumont/TerradaceFY2022£34kBeaumont/Terradace (Marsh) This project intends to understand the lifecycle and development of HPV infections within the mouth to determine how HPV causes head and neck cancer, in order to develop new treatments.
Beaumont/ TerradaceFY2022£32kBeaumont/ Terradace (Patin) The aim of this project is to use drugs to make radiation more effective in killing cancer cells, but also to alert the immune system to their presence.
AMRC (Patin)FY2022£31kThe work of Daniel Lin will study baseline I DO activity in patients and map this throughout head and neck cancer (HNC) treatment to establish IDO as a biomarker for HNC and support a more personalised therapeutic approach to improve patient outcomes.
CHK CharitiesFY2022£12kCHK Charities are supporting PhD student, Jennifer Kieselmann, to undertake a cutting edge computationai project at the ICR's Division of Radiotherapy and imaging.
AMRC (Lin)FY2022£2kThe work of Daniel Lin will study baseline I DO activity in patients and map this throughout head and neck cancer (HNC) treatment to establish IDO as a biomarker for HNC and support a more personalised therapeutic approach to improve patient outcomes.
The Worshipful Company of MercersFY2022£200Funding to support the production of awareness materiais.
Pennycress TrustFY2022£200Match funded by Pioneers of Discovery fund, supporting PhD fellows.

About this data

This grant list is extracted by automated reading of the grant-maker’s own accounts PDFs as filed with the Charity Commission, and cross-checked against the accounts’ stated grant totals (no individually listed grants). Recipients are linked to register entries only on an exact charity-number or unambiguous exact-name match. If you represent this funder and want a correction, contact us.